PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.67%
Negative net income growth while ORCL stands at 10.19%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
13.25%
D&A growth well above ORCL's 20.81%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-32.37%
Negative yoy deferred tax while ORCL stands at 119.05%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
15.12%
SBC growth well above ORCL's 13.46%. Michael Burry would flag major dilution risk vs. competitor’s approach.
44.37%
Well above ORCL's 61.43% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
154.85%
AR growth well above ORCL's 97.76%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-101.41%
Both reduce yoy inventory, with ORCL at -51.22%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-529.29%
Both negative yoy AP, with ORCL at -170.62%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
22.45%
Lower 'other working capital' growth vs. ORCL's 85.95%. David Dodd would see fewer unexpected short-term demands on cash.
-8.63%
Negative yoy while ORCL is 75.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
69.39%
Operating cash flow growth below 50% of ORCL's 148.53%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
14.74%
Lower CapEx growth vs. ORCL's 41.88%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
96.76%
Acquisition spending well above ORCL's 93.66%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
6.11%
Some yoy expansion while ORCL is negative at -19.75%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-28.42%
We reduce yoy sales while ORCL is 32.74%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-200.93%
We reduce yoy other investing while ORCL is 206.02%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
58.03%
Investing outflow well above ORCL's 92.51%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
94.88%
Debt repayment growth of 94.88% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
36.64%
Lower share issuance yoy vs. ORCL's 117.37%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
42.71%
Repurchase growth above 1.5x ORCL's 6.50%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.